Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 2Breast 1

Conditions

Malignant Solid Neoplasm 1Breast Neoplasms 1Advanced Cancers 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Asian ginseng × 1 year × Clear all
NCT00631852 2026-05-12

A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer

Southern Illinois University

Phase 2 Completed
16 enrolled 28 charts
Breast

Breast Neoplasms

NCT01375114 2026-05-04

The Effects of Ginseng on Cancer-Related Fatigue

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
165 enrolled 14 charts
Other solid neoplasm

Advanced Cancers

NCT06395441 2026-03-30

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

Mayo Clinic

Phase 3 Recruiting
160 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡